Management of Heart Failure Exacerbation with Diuretics

Initial Dose Adjustment Strategy

• For patients on chronic diuretic therapy experiencing heart failure exacerbation, the European Society of Cardiology recommends increasing the IV furosemide dose to at least the equivalent of their oral dose, and administering either as intermittent boluses or continuous infusion, adjusting based on clinical response while monitoring renal function and electrolytes closely 1, 2
• The initial IV dose for patients already on oral furosemide should be at least equivalent to the current oral dose, according to the European Heart Journal 1, 2
• For new-onset acute heart failure not on diuretics, the European Heart Journal suggests starting with 20-40 mg IV furosemide 1, 2
• Either intermittent boluses or continuous infusion are equally acceptable administration methods, as stated by the European Heart Journal 1, 2

Special Considerations with Impaired Renal Function

• When creatinine is elevated or eGFR is low, the European Journal of Heart Failure recommends seeking specialist advice before escalating doses 3
• The European Journal of Heart Failure advises against using thiazide diuretics as monotherapy when GFR is less than 30 mL/min, though they can be combined synergistically with loop diuretics for resistant edema 3, 5
• The European Journal of Heart Failure suggests checking renal function and electrolytes 1-2 weeks after initiation or dose changes 3

Blood Pressure Considerations

• When systolic BP is less than 90 mmHg, the European Journal of Heart Failure recommends seeking specialist advice before initiating or increasing diuretics 3
• The European Journal of Heart Failure notes that asymptomatic low blood pressure alone is not a contraindication if signs of congestion persist 3

Electrolyte Management

• The European Journal of Heart Failure recommends correcting hypokalemia before escalating diuretic doses 3
• The European Heart Journal advises avoiding potassium-sparing diuretics during initial ACE inhibitor titration 5
• The European Journal of Heart Failure suggests monitoring serum electrolytes frequently during the first few months and periodically thereafter 6

Combination Diuretic Therapy for Refractory Cases

• The European Heart Journal recommends increasing the loop diuretic dose first when response is insufficient 5
• The European Journal of Heart Failure suggests considering combining loop diuretics with thiazides for synergistic effect 3, 5, 6

Continuation of Disease-Modifying Therapies

• The European Heart Journal recommends continuing evidence-based therapies, such as ACE inhibitors and beta-blockers, during acute exacerbation, unless hemodynamic instability or contraindications exist 1, 2

Common Pitfalls to Avoid

• The European Journal of Heart Failure advises against using thiazides alone when GFR is less than 30 mL/min, as they are ineffective as monotherapy 3, 5
• The European Journal of Heart Failure recommends avoiding inadequate monitoring of renal function and electrolytes after dose changes 3
• The European Journal of Heart Failure suggests avoiding NSAIDs unless essential, as they may attenuate diuretic effect and cause renal impairment 3